Effects of Phytonutrients Upon Muscle Perfusion in Response to Feeding
NCT ID: NCT03213340
Last Updated: 2020-01-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
39 participants
INTERVENTIONAL
2017-09-14
2019-10-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Muscle Health and Recovery in Older Adults
NCT06205537
Effects of a Pre-Workout on Performance, Perceptual Responses, Energy Feelings and Muscular Properties, After a Training Microcycle in Adults.
NCT04147741
Effects of a Multi-Ingredient Pre-Workout Supplement on Body Composition, Performance, Muscular Properties, and Wellbeing in Adults.
NCT05769088
NAD Supplementation Study
NCT03310034
Effects of a Recovery Supplement on Body Composition, Performance, Muscular Properties, and Wellbeing
NCT05769101
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Catechin Cohort 1
2 treatment - Experimental Catechin Blend; Control 1 Placebo
Catechin Cohort 1
\- 4 capsules taken with water 1 hour prior to meal
Curcuminoid Cohort 2
2 treatment - Experimental Curcuminoid Blend; Control 1 Placebo
Curcuminoid Cohort 2
\- 2 capsules taken with water 1 hour prior to meal
Flavonoid Cohort 3
2 treatment - Experimental Flavonoid Blend; Control 2 Low-Flavonoid Blend
Flavonoid Cohort 3
\- \~ 1 oz. serving consumed 30 minutes before meal
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Catechin Cohort 1
\- 4 capsules taken with water 1 hour prior to meal
Curcuminoid Cohort 2
\- 2 capsules taken with water 1 hour prior to meal
Flavonoid Cohort 3
\- \~ 1 oz. serving consumed 30 minutes before meal
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Free from active metabolic disease
* Normotensive
Exclusion Criteria
* Smokers
* Surgery within past 3 months
* Active cardiovascular disease
* Taking beta-adrenergic blocking agents
* Cerebrovascular disease:
* Active respiratory disease
* Active metabolic disease
* Active inflammatory bowel or renal disease
* Active Malignancy or until confirmed remission
* Clotting dysfunction
* History of DVT
* Significant musculoskeletal or neurological disorders
* Family history of early (\<55y) death from cardiovascular disease
* Known sensitivity to Sonovue contrast agent
* Known allergy or intolerance to any of the study ingredients
* Current use of any of the study ingredients
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Nutrition
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Suzette Pereira, PhD
Role: STUDY_CHAIR
Abbott Nutrition
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Nottingham
Derby, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BL31
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.